(Q37261506)

19 August 2017

1 reference

title

Evidences of parasite evolution after vaccination (English)

1 reference

19 August 2017

Sylvain Gandon

1

0 references

Troy Day

object named as

Troy Day

series ordinal

2

0 references

language of work or name

English

0 references

publication date

1 July 2008

1 reference

19 August 2017

1 reference

19 August 2017

26 Suppl 3

1 reference

19 August 2017

C4-7

1 reference

The evolutionary epidemiology of vaccination

19 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.007

Vaccine-induced escape mutant of hepatitis B virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.007

Changes of hepatitis B surface antigen variants in carrier children before and after universal vaccination in taiwan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.007

Current status of HBV vaccine escape variants--a mathematical model of their epidemiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.007

The predicted pattern of emergence of vaccine-resistant hepatitis B: a cause for concern?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.007

Role of the polymorphic region 1 of the Bordetella pertussis protein pertactin in immunity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.007

Adaptation of Bordetella pertussis to vaccination: a cause for its reemergence?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.007

Acquisition and invasiveness of different serotypes of Streptococcus pneumoniae in young children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.007

Bacterial vaccines and serotype replacement: lessons from Haemophilus influenzae and prospects for Streptococcus pneumoniae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.007

Carriage of pneumococci after pneumococcal vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.007

Vaccine efficacy: winning a battle (not war) against malaria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.007

Vaccine-induced immunity to malaria parasites and the need for novel strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.007

Malaria vaccines 1985-2005: a full circle?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.007

A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.007

Immunity promotes virulence evolution in a malaria model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.007

Genetic Relationships between Parasite Virulence and Transmission in the Rodent Malaria Plasmodium chabaudi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.007

The effects of host immunity on virulence-transmissibility relationships in the rodent malaria parasite Plasmodium chabaudi.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.007

Virulence in malaria: an evolutionary viewpoint

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.007

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.007

The changing epidemiology of diphtheria in the vaccine era.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.007

A toxoid vaccine for pertussis as well as diphtheria? Lessons to be relearned

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.007

Microbial evolution (Communication arising): Antitoxin vaccines and pathogen virulence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.007

Imperfect vaccines and the evolution of pathogen virulence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.007

Imperfect vaccination: some epidemiological and evolutionary consequences.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.007

VACCINATION, WITHIN-HOST DYNAMICS, AND VIRULENCE EVOLUTION

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.007

IMPERFECT VACCINES AND THE EVOLUTION OF PATHOGENS CAUSING ACUTE INFECTIONS IN VERTEBRATES

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.007

Vaccination, evolution and changes in the efficacy of vaccines: a theoretical framework.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.007

Mathematical models of vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.007

After the honeymoon in measles control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.007

Licensed recombinant hepatitis B vaccines protect chimpanzees against infection with the prototype surface gene mutant of hepatitis B virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.007

10.1016/J.VACCINE.2008.02.007

7 January 2021

Identifiers

DOI

1 reference

19 August 2017

1 reference

PubMed ID

18773527